Surgical Snares Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Usability (Single-use, Reusable), By Application (GI Endoscope, Laparoscopy, Urology Endoscopy, Gynecology, Endoscopy, Arthroscopy, Bronchoscopy, Mediastinoscopy, Laryngoscopy, Others), By End-use (Hospitals, Ambulatory Surgical Centers, Others)) Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.81 Billion
CAGR (2026-2031)	6.63%
Fastest Growing Segment	GI Endoscope
Largest Market	North America
Market Size (2031)	USD 2.66 Billion

Market Overview

The Global Surgical Snares Market will grow from USD 1.81 Billion in 2025 to USD 2.66 Billion by 2031 at a 6.63% CAGR. Surgical snares are specialized medical instruments featuring a wire loop designed for the endoscopic excision of polyps and tumors from the gastrointestinal tract. The primary driver supporting market growth is the increasing global incidence of colorectal cancer which necessitates frequent screening and minimally invasive therapeutic interventions. This demand is further amplified by the clinical shift toward early detection programs that utilize these devices for immediate polyp removal. According to the American Cancer Society, in 2025, approximately 154,270 new cases of colorectal cancer were estimated to be diagnosed in the United States. This high disease burden directly sustains the necessity for effective electrosurgical removal tools.

Conversely, a significant challenge impeding market expansion is the risk of procedural complications such as perforation or hemorrhage during polypectomy. These safety concerns necessitate advanced operator proficiency and can limit device adoption in facilities lacking specialized training infrastructure. Consequently, the steep learning curve associated with safe device manipulation remains a barrier to broader utilization in developing healthcare markets where access to skilled endoscopists is often restricted.

Key Market Drivers

The proliferation of government-led colorectal cancer screening programs is a primary catalyst propelling the global surgical snares market. Public health initiatives aimed at early detection are significantly increasing the volume of diagnostic and therapeutic endoscopies, thereby elevating the demand for polypectomy devices. By mandating or subsidizing preventive screenings, healthcare systems are identifying more patients requiring immediate polyp removal, which directly sustains the consumption of these single-use instruments. For instance, according to the American Cancer Society National Colorectal Cancer Roundtable, August 2025, in the '2024 Prevention and Screening Program' report, the total number of patients screened for colorectal cancer in participating health centers reached 3,617,246 in 2024. This high screening volume is critical given the disease's severity; according to the American Cancer Society, January 2025, in 'Cancer Facts & Figures 2025', colorectal cancer was projected to cause approximately 52,900 deaths in the United States, underscoring the urgent clinical necessity for effective excision tools.

Simultaneously, technological advancements in surgical snare design are driving market value and adoption by improving procedural safety and efficacy. Manufacturers are increasingly introducing specialized devices, such as cold snares and rotatable hybrid models, which minimize the risk of thermal injury and perforation associated with traditional electrosurgery. These innovations allow endoscopists to perform complex resections with greater confidence, thereby encouraging the transition toward minimally invasive techniques in outpatient settings. Validating this robust demand for advanced medical solutions, according to Boston Scientific, October 2025, in the 'Third Quarter 2025 Earnings Report', the company generated net sales of $5.07 billion, representing a 20.3% increase compared to the prior year. Such financial growth reflects the expanding adoption of next-generation endoscopic technologies in modern clinical practice.

Download Free Sample Report

Key Market Challenges

The risk of procedural complications, specifically perforation and hemorrhage during polypectomy, presents a substantial barrier to the expansion of the Global Surgical Snares Market. This safety challenge necessitates a high degree of operator proficiency, creating a steep learning curve that restricts device adoption in facilities lacking specialized training infrastructure. In developing healthcare markets where access to skilled endoscopists is already limited, the potential for adverse events discourages the widespread utilization of these electrosurgical tools, thereby dampening market growth potential.

The material impact of these safety concerns is underscored by recent clinical data. According to the American Association for Cancer Research, in 2025, a large-scale cohort study indicated that patients undergoing screening colonoscopies faced a 1.04% risk of serious complications, including hospitalization or death within 30 days, often stemming from procedural interventions. This statistical evidence of adverse event risks reinforces the necessity for advanced operator competency. Consequently, healthcare providers in resource-constrained settings may defer the adoption of advanced snare devices, directly hampering the market’s ability to penetrate non-specialized global regions.

Key Market Trends

The migration of endoscopic procedures to Ambulatory Surgery Centers is reshaping the market landscape as healthcare providers seek cost-effective and high-throughput alternatives to traditional hospital settings. This operational shift effectively decentralizes polyp removal services, allowing for faster patient turnover and increased procedure volumes that directly fuel the consumption of polypectomy devices. Validating this expansion in outpatient procedural volume, according to Surgery Partners, November 2025, in the 'Third Quarter 2025 Earnings Report', the company achieved a 3.4% year-over-year increase in same-facility surgical cases, driven by sustained demand in gastrointestinal and musculoskeletal service lines.

Simultaneously, there is an accelerated transition toward single-use disposable snares to eliminate the cross-contamination risks associated with difficult-to-clean reusable instruments. Hospitals and clinics are increasingly prioritizing infection prevention protocols, prompting a procurement shift away from capital-intensive reusable accessories in favor of sterile solutions that ensure consistent performance and patient safety. Reflecting this robust demand for infection-control consumables, according to STERIS plc, May 2025, in the 'Fiscal 2025 Fourth Quarter and Full Year Financial Results', revenue from healthcare consumables grew by 6% in the fourth quarter, underscoring the market's continued pivot toward disposable procedural tools.

Segmental Insights

The GI Endoscope segment is positioned as the fastest-growing category within the Global Surgical Snares Market, primarily driven by the escalating prevalence of colorectal cancer and gastrointestinal disorders. This robust expansion is supported by the increasing clinical preference for minimally invasive polypectomies, which utilize snares for the precise resection of abnormal tissues. Furthermore, influential institutions such as the American Cancer Society have intensified their advocacy for regular colorectal screenings, directly amplifying the volume of diagnostic and therapeutic endoscopic procedures globally. This heightened focus on early detection and preventative care continues to accelerate the demand for specialized gastrointestinal snares.

Regional Insights

North America maintains a dominant position in the global surgical snares market, primarily driven by the rising incidence of gastrointestinal disorders and colorectal cancer. This leadership is supported by established healthcare infrastructure that facilitates the widespread adoption of minimally invasive endoscopic procedures. Additionally, favorable reimbursement policies covering cancer screenings, established by institutions such as the Centers for Medicare & Medicaid Services, significantly drive procedural volumes. The market landscape is further strengthened by the strict regulatory oversight of the U.S. Food and Drug Administration, which ensures the continuous availability of safe and effective medical devices for clinical use.

Recent Developments

• In September 2024, a major corporation in the optical and digital precision technology sector received FDA 510(k) clearance for its cloud-based artificial intelligence system, CADDIE. This computer-aided detection device assists gastroenterologists in identifying potential colorectal polyps during colonoscopies. By leveraging AI to highlight suspected lesions in real-time, the technology aims to improve adenoma detection rates, a critical metric in preventing colorectal cancer. The clearance of this system underscores the industry's shift towards integrating digital advancements with traditional surgical tools, such as snares, to enhance the accuracy and efficacy of polypectomy procedures in the "Global Surgical Snares Market".
• In August 2024, two prominent players in the medical device industry formed a strategic partnership to deliver integrated solutions for gastrointestinal endoscopy suites. The collaboration involved the joint marketing of high-performance flexible endoscopes from one partner alongside the other's state-of-the-art operating room integration systems. This alliance targeted both hospitals and ambulatory surgery centers, aiming to streamline clinical workflows and enhance the environment for endoscopic procedures. By combining superior visualization technology with efficient room integration, the companies sought to support endoscopists in performing precise interventions, such as polyp resections, thereby contributing to better clinical outcomes in the "Global Surgical Snares Market".
• In March 2024, the Chairman of Boston Scientific announced an expanded strategic cooperation agreement with Scivita Medical Technology to enhance the distribution of endoscopic devices. This collaboration focused on accelerating the commercialization of single-use endoscopes and imaging solutions across China and various international markets. By integrating these innovative technologies into its broad endoscopy portfolio, the company aimed to address the increasing demand for effective diagnostic and therapeutic tools in gastroenterology. This strategic move was designed to provide healthcare professionals with greater access to advanced equipment necessary for performing high-quality endoscopic procedures and improving patient care standards within the "Global Surgical Snares Market".
• In January 2024, a medical device company focused on surgical endoscopy announced the successful first use of its Speedboat UltraSlim device in the Asia Pacific region. This event marked a crucial step in the phased global rollout of the technology, which had previously been introduced in the United States and Europe. The device, an advanced energy instrument used for the resection of gastrointestinal lesions, offers a miniaturized design compatible with the majority of endoscopes. This compatibility allows clinicians to perform complex therapeutic procedures, such as the removal of precancerous polyps, using standard endoscopic equipment, thereby expanding access to minimally invasive treatments in the "Global Surgical Snares Market".

Key Market Players

• Medtronic Plc
• Boston Scientific Corporation
• Medline Industries, Inc.
• Olympus Corporation
• Cook Medical Inc.
• CONMED Corporation
• Merit Medical Systems
• Avalign Technologies
• Hill-Rom Holdings, Inc.
• Sklar Surgical Instruments.

By Usability	By Application	By End-use	By Region
Single-use Reusable	GI Endoscope Laparoscopy Urology Endoscopy Gynecology Endoscopy Arthroscopy Bronchoscopy Mediastinoscopy Laryngoscopy Others	Hospitals Ambulatory Surgical Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Surgical Snares Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Surgical Snares Market, By Usability:

• Single-use
• Reusable

• Surgical Snares Market, By Application:

• GI Endoscope
• Laparoscopy
• Urology Endoscopy
• Gynecology
• Endoscopy
• Arthroscopy
• Bronchoscopy
• Mediastinoscopy
• Laryngoscopy
• Others

• Surgical Snares Market, By End-use:

• Hospitals
• Ambulatory Surgical Centers
• Others

• Surgical Snares Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE